Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

About Pharma in Focus

Pharma in Focus has served the Australian and New Zealand pharma industry since 2003. Published twice daily, it is distributed to 10,000 readers by email alert or mobile app.

Pharma in Focus reports on all aspects of the pharmaceutical industry from the drug pipeline to regulatory, reimbursement, legal, employment, government and corporate matters.

Our editorial staff (see below) is dedicated to providing the industry with accurate, timely, balanced news and commentary every business day. With more than 17 years in the business, Pharma in Focus is Australia's most trusted source of pharma news.

Our editorial team

Megan Brodie – Editor

Megan has worked in journalism and corporate affairs for three decades. Her previous roles include News Ltd State Political Reporter, NSW Government Media Adviser, NRMA Insurance (now IAG) Media Adviser as well as consulting to a number of public and private clients.

Megan joined Pharma in Focus in 2012 as Research Manager and Senior Journalist. She was promoted to Editor in 2017. She holds a Bachelor of Communications, Journalism and Politics, from Charles Sturt University.

Christine Spiteri – News Editor/Senior Writer

Christine has worked in news journalism for more than 30 years across print, broadcast and digital. She reported for News Limited publications for eight years including five as a medical reporter before joining Nine Network Australia where she covered politics, courts and general news as well as presenting news bulletins.

Between 2005 and 2008, she was the network's foreign correspondent covering the US, Europe and the Middle East. More recently, Christine was news editor for New Idea magazine and worked in consulting roles.

Tiffany Walker – Journalist

Tiffany has a bachelor's degree in medical science and a masters in science in medicine (pharmaceutical and medical device development) from the University of Sydney.

Tiffany covers the corporate social responsibility and general news rounds and prepares the weekly Approvals Action features for Pharma in Focus.

Nick Lush – Publisher, Managing Director

Nick founded Pharma in Focus in 2003 and served as its full-time editor until October 2017. While maintaining a supervisory role in daily editorial management he is now driving a number of new projects for Pharma in Focus and its parent, Lush Media.

Nick has 35-plus years working in journalism and publishing with a strong emphasis on news, especially medical and pharmaceutical. Before starting Pharma in Focus in 2003, he was editor of Medical Observer, a weekly news magazine for Australian general practitioners.

Our subscriptions, access and advertising team

Jane Cameron – Subscriptions Manager

Jane established the Pharma in Focus subscription management function in 2003 and has built the publication's circulation to its current figure of more than 10,500 readers across Australian and New Zealand pharma.

Andrea Kavanagh – Subscriptions Associate

Andrea joined Pharma in Focus in 2016. She manages day to day subscriptions and access activity. Andrea has a great understanding of the pharma industry, having worked for a number of years at Roche before joining Pharma in Focus.

Fiona Oldfield – Subscriptions Associate

Fiona assists both Andrea and Jane in subscriptions and access management. She has been with Pharma in Focus since the start of 2018 and, like her colleague Andrea, was formerly in administrative roles at Roche.

Tracey Day – Group Sales Executive, Advertising

Tracey is your contact for all advertising inquiries. She has been looking after Pharma in Focus advertising clients since 2016, advising on everything from structuring campaigns to designing advertisements. Before joining Pharma in Focus, Tracey was a sales executive at The Media Company.

Special Report
Aust Covid Vaccine Tracker
Live updates on frontrunners, local trials and deals
Top of the Hill
If only for a 2020 time machine
What would you do if you could start this year again?
Approvals Action
Bayer's oral pan-tumour ticked
Vitrakvi provisionally approved for NTRK-fusion cancer